Part D drug consolidation could save Medicare $150 million, CMS finds

Share this article:

Consolidating drugs covered by Medicare Part B and Part D under Part D could save Medicare nearly $150 million, according to a new report from the Centers for Medicare & Medicaid Services.

By contrast, the report found that consolidating drugs under Medicare Part B could increase Medicare spending by $52 million. 

Though the vast majority of drugs for seniors are covered under the Medicare Part D program, there are still some drugs covered through Part B. These drugs include injectable insulin, certain vaccines—including for influenza—and drugs dispensed by nebulizer.

While the consolidation under Medicare Part D could save the program money, it would adversely impact Medicare beneficiaries in the pocketbook, the report found. Because Part D has “less generous coverage rules,” switching the coverage of drugs from Part B to Part D would cost beneficiaries roughly $267 in added out-of-pocket expenses. 

Share this article:

More in News

A small team of workers responds best in emergencies, expert says

A small team of workers responds best in ...

Long-term care providers should consider a "flat" crisis management approach that relies on a core group of staff members, experts advised Wednesday at the LeadingAge annual conference.

Nursing homes have better pain and catheter management if leaders have more ...

Nursing homes led by administrators and directors of nursing with higher levels of education and certification have better outcomes on some key quality measures, according to recently published findings.

Court green-lights charges that a healthcare network underused observation stays

A whistleblower can continue to pursue charges that a Nevada healthcare network routinely admitted people as hospital inpatients when they should have been placed in observation status, a federal appeals court recently ruled.